| 翻訳と辞書 |
| Donald Jensen ： ウィキペディア英語版 |
Donald Jensen
Donald Jensen (born 1946) is an American hepatitis C researcher who works at the University of Chicago. He attended high school in Springfield, IL, and was an undergraduate at the University of Illinois in Champaign-Urbana. He attained his MD degree from the University of Illinois in Chicago in 1972, and completed an internal medicine residency and chief medical resident at Rush University from 1972-1976. From 1976-1977, he was a liver research fellow at King's College Hospital in London, UK, before returning to Rush as a faculty member. In 1999, he was appointed as the Richard B. Capps Professor of Medicine and chief of the section of hepatology. In 2005, he moved to the University of Chicago as professor of medicine and director of the Center for Liver Disease. In December, 2014, he retired from his position at the University of Chicago Medicine.
In early 1990s he was a clinical investigator at Rush University who helped to develop a drug interferon for hepatitis C, and in 1998 assisted in the development of the combination of interferon and ribavirin for the treatment of chronic hepatitis C. In 2007, Dr. Jensen was featured as the Top Doc in Chicago Magazine (http://www.uchospitals.edu/news/2007/20071217-top-doctors.html). In May 2011, two new antiviral agents for which he performed investigations, have been released: telaprevir and boceprevir.
==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Donald Jensen」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|